NCT04981665 2022-01-05A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionZhejiang UniversityPhase 2 Unknown50 enrolled
NCT04539444 2021-08-02A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell LymphomaThe First Affiliated Hospital of Soochow UniversityPhase 2 Unknown10 enrolled